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Objective: To study the change of serum C-reactive protein (CRP) levels and its cor-
relation with ketosis in type 2 diabetes mellitus patients with acute ketosis intoxication.
Methods: A retrospective analysis was conducted for the patients with type 2 diabetes
mellitus from August 2015 to January 2016. The patients combined with ketosis were
included into diabetic ketosis group and the patients without ketosis were included into
negative control group. The clinical data were collected from two groups including
general data, blood pressure, liver function and the levels of blood fat, glycosylated
hemoglobin, blood ketone, b-hydroxybutyric acid and CRP. The discrepancy of clinical
data between two groups was analyzed.
Results: The levels of glycosylated hemoglobin [(11.6 ± 2.1)% vs. (8.3 ± 1.9)%], blood
ketone [0.65 (0.3, 1.75) vs. 0.1 (0.1, 0.2) mmol/L], b-hydroxybutyric acid [0.595 (0.303,
1.775) vs. 0.08 (0.06, 0.15) mmol/L] and CRP [0.595 (0.303, 1.775) vs. 0.08 (0.06, 0.15)
mmol/L] were signiﬁcant higher than those of negative control group, while the levels of
blood pressure, blood fat and aminopherase had no signiﬁcant difference. The serum CRP
levels showed positive correlation with blood ketone and b-hydroxybutyric acid
(r = 0.490 and r = 0.478, respectively).
Conclusions: Poor blood glucose control for a long time and strengthening inﬂammatory
response are correlated with the status of acute ketosis in type 2 diabetes mellitus patients.
The CRP levels in ketosis patients were signiﬁcantly elevated and could be used to
evaluate the degree of ketosis.1. Introduction
Diabetic ketosis (DK) is one of the common acute complica-
tions in diabetes mellitus patients and this disease caused by
ketosis has always been considered as the important feature of type
1 diabetes mellitus [1,2]. Nevertheless, in recent years, more and
more foreign scholars found that type 2 diabetes mellitus is also
quite common in diabetes mellitus patients caused by ketosis
and ketoacidosis. Umpierrez research showed that the ratio oftype 2 diabetes mellitus is taking up more than half in Afro-
American diabetes mellitus patients caused by ketoacidosis[3].
Kim study revealed that the ratio of type 2 diabetes mellitus is
up to 40% in Korean diabetes mellitus patients caused by
ketoacidosis[4]. Therefore, clinical scholars pay more attention to
these type 2 diabetes mellitus patients combined with ketosis.
All DK patients are in an acute and inﬂammatory condition.
Acute phase reactive protein CRP, proinﬂammatory cytokine IL-
6 and suppression of inﬂammatory cytokine IL-10 have a large
number of synthesis and secretion in an acute condition[5–7]. A
number of studies have conﬁrmed that CRP levels are
signiﬁcant higher and related with the degree of severity of
ketosis in the serum of type 1 diabetes mellitus patients
combined with ketosis[8–10]. However, the synthetic condition
of CRP has not been reported clearly in the body of type 2
diabetes mellitus patients combined with ketosis so far. CRP is
a kind of acute phase reactive protein, which is compounded
and secreted from hepatic cell under inducing of
proinﬂammatory cytokine such as IL-6 and so on and can
participate in inﬂammatory response by activating inﬂammatory
factors secreted from macrophage and promoting inﬂammatoryer the CC BY-NC-ND license (http://
Table 1
General clinical data of two group patients.
Parameter DK (n = 39) NC group (n = 61) P
Gender (male/female) 28/11 39/22 > 0.05
Age (years) 47.8 ± 12.4 55.5 ± 10.8 < 0.01
BMI (kg/m2) 23.9 ± 3.1 24.7 ± 2.9 > 0.05
SBP (mmHg) 127.2 ± 13.2 130.7 ± 19.8 > 0.05
DBP (mmHg) 83.8 ± 8.6 84.7 ± 12.3 > 0.05
TG (mmol/L) 5.5 ± 1.8 5.2 ± 1.3 > 0.05
TC (mmol/L) 2.0 ± 0.76 2.1 ± 1.5 > 0.05
ALT (IU/L) 24.1 ± 12.7 27.8 ± 14.5 > 0.05
AST (IU/L) 19.7 ± 11.9 21.8 ± 14.5 > 0.05
HbA1c (%) 11.6 ± 2.1 8.3 ± 1.9 < 0.01
HbA1c: Glycosylated hemoglobin.
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analyze the change of serum C-reactive protein (CRP) levels and
its correlation with ketosis in type 2 diabetes mellitus patients
with acute ketosis intoxication.
2. Materials and methods
2.1. Study object
A total of 100 type 2 diabetes mellitus patients were
collected randomly from Department of Endocrinology, the
117th Hospital of Chinese People's Liberation Army from
August 2015 to January 2016 and were retrospectively
analyzed. Inclusion and exclusion criteria of cases were as
follows: (1) met the diagnostic criteria for type 2 diabetes
mellitus established by World Health Organization (1999); (2)
all the serum glutamic acid decarboxylase antibody (GAD-Ab),
islet cell cytoplasmic antibody (ICA) and insulin autoantibody
were negative; (3) type 1 diabetes mellitus, gestational diabetes
mellitus and other speciﬁc types of diabetes mellitus were
excluded and (4) the patients with a state of infection and fever
after operation were excluded. In 100 patients, 67 cases were
male and 33 cases were female. A total of 52 cases were
received the treatment of oral hypoglycemic drugs, 11 cases
were received insulin treatment and 37 cases were received the
treatment of oral hypoglycemic drugs combined with insulin.
According to the following criteria to judge ketosis: blood
glucose levels were more than 13.9 mmol/L and ketonuria was
more than 1+. A total of 39 cases diagnosed with ketosis were
collected into DK group and 61 cases not combined with ketosis
diagnosis were collected into NC group.
2.2. Clinical data collection
After admitting to hospital, all patients received a physical
examination and measurement to record the height and weight
and calculate body weight index (BMI). Riva-rocci sphygmo-
manometer was used to measure systolic pressure (SBP) and
diastolic pressure (DBP). Peripheral vein blood was collected
under the fasting state. Beckman fully automatic biochemical
analyser was used to detect triglyceride (TG), total cholesterol
(TC), alanine aminotransferase (ALT), aspartate aminotrans-
ferase (AST) and b-hydroxybutyric acid levels. Clean catch
midstream urine was collected and urine acetone bodies levels
were disposed with semi-quantitative analysis by chemical
method. After collecting terminal blood, blood ketone levels
were detected by Optium Xceed blood ketone instrument man-
ufactured from Abbott Company. Full-automatic Aﬁnion AS100
Analyzer (Aﬁnion Company) was used to measure glycosylated
hemoglobin levels.
2.3. Statistical methods
SPSS 20.0 software was used to input data. Measurement
data were examined using homogeneity of variance of which the
data accorded to homogeneity of variance were expressed as
mean ± SD and were analyzed by t-test, while the data not
accorded to homogeneity of variance were expressed as median
(P25, P75) and were analyzed by nonparametric rank and in-
spection. Enumeration data were expressed as frequency and
were analyzed by Chi-square test. The correlativity between twovariables was analyzed by Pearson correlation. Difference was
statistically signiﬁcant (P < 0.05).
3. Results
3.1. General clinical data of two group patients
DK group included 28 male cases and 11 female cases
[(47.8 ± 12.4) years, (23.9 ± 3.1) kg/m2 BMI, (127.2 ± 13.2)
mmHg SBP, (83.8 ± 8.6) mmHg DBP, (5.5 ± 1.8) mmol/L TG,
(2.0 ± 0.76) mmol/L cholesterol, (24.1 ± 12.7) IU/mL ALT,
(19.7 ± 11.9) IU/mL AST and 11.6% ± 2.1% glycosylated he-
moglobin]. NC group included 39 male cases and 22 female
cases [(55.5 ± 10.8) years, (24.7 ± 2.9) kg/m2 BMI,
(130.7 ± 19.8) mmHg SBP, (84.7 ± 12.3) mmHg DBP,
(5.2 ± 1.3) mmol/L triglyceride, (2.1 ± 1.5) mmol/L cholesterol,
(27.8 ± 14.5) IU/mL ALT, (21.8 ± 14.5) IU/mL AST and
8.3% ± 1.9% glycosylated hemoglobin]. According to statistic
analysis, the gender, BMI, blood pressure and triglyceride,
cholesterol, AST and ALT levels of DK group had no signiﬁcant
difference with NC group. The age in DK group was signiﬁcant
lower than NC group, while glycated hemoglobin levels were
signiﬁcant higher than those in NC group (Table 1).
3.2. Blood ketone and b-hydroxybutyric acid levels of
patients in two groups
After homogeneity of variance test, blood ketone and b-hy-
droxybutyric acid levels of two groups were not accordant with
homogeneity of variance and were expressed as median (P25,
P75). In DK group, blood ketone level was [0.65 (0.3, 1.75)]
mmol/L and b-hydroxybutyric acid level was [0.595 (0.303,
1.775)] mmol/L. In NC group, blood ketone level was [0.1 (0.1,
0.2)] mmol/L and b-hydroxybutyric acid level was [0.08 (0.06,
0.15)] mmol/L. After nonparametric rank sum test, blood ketone
and b-hydroxybutyric acid levels of patients in DK group were
signiﬁcant higher than NC group (Figure 1).
3.3. Serum CRP contents of patients in two groups
According to homogeneity of variance test, serum CRP
contents of patients in two groups were not accordant with ho-
mogeneity of variance and were expressed as median (P25,
P75). Serum CRP contents of patients in DK group {[4.78 (2.85,
7.63)] mg/L} were signiﬁcant higher than serum CRP contents
in NC group {[2.45 (2.10, 3.07)] mg/L} (Figure 2).
Figure 1. Blood ketone and b-hydroxybutyric acid contents in two groups.
Left: Blood ketone contents of patients in DK group {[0.65 (0.3, 1.75)] mmol/L} were signiﬁcant higher than those in NC group {[0.1 (0.1, 0.2)] mmol/L},
Z = 7.215, P < 0.001; Right: b-hydroxybutyric acid contents of patients in DK group {[0.595 (0.303, 1.775)] mmol/L} were signiﬁcant higher than those in
NC group {[0.08 (0.06, 0.15)] mmol/L}, Z = 6.776, P < 0.001; **: P < 0.01. Data were expressed as median (P25, P75).
Figure 2. Serum CRP contents of patients in two groups.
Serum CRP contents of patients in DK group {[4.78 (2.85, 7.63)] mg/L}
were signiﬁcant higher than those in NC group {[2.45 (2.10, 3.07)] mg/L},
P < 0.001. Data were expressed as median (P25, P75). **: P < 0.01.
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Through Pearson correlation analysis, the correlativity of
CRP contents, blood ketone and b-hydroxybutyric acid contents
showed that CRP contents presented positive correlation with
blood ketone and b-hydroxybutyric acid contents (r = 0.490 and
0.478, respectively) (P < 0.01) (Figure 3).Figure 3. The correlation of serum CRP contents, blood ketone and b-hydrox
Left: The correlation of serum CRP contents and blood ketone contents, r
b-hydroxybutyric acid contents, r = 0.478, P < 0.01.4. Discussion
Ketone body is a product of incomplete oxidation in internal
fat. As the aggravation of diabetes mellitus, the metabolic dis-
orders of three major matters and the increasing of lipid mobi-
lization and decomposition, b-oxidation can occur in a large
number of fatty acids that produce a plenty of b-hydroxybutyric
acid, acetoacetic acid and acetone, which are collectively
referred to as the ketone body[11–13]. When the generation of
ketone body increases and exceeds the oxidizing ability of
extrahepatic tissue, ketone body contents are signiﬁcant higher
and the discharge of urine acetone body increases and
becomes ketonuria, which is referred as ketosis clinically[14,15].
DK is one of the common acute complications in diabetes
mellitus patients and the majority of type 1 diabetes mellitus
patients are caused by ketoacidosis[16–18]. In recent years, more
and more foreign scholars found that type 2 diabetes mellitus
patients are also caused by ketosis and ketoacidosis[3,4]; the
reasons include obesity, insulin resistance and poor control of
blood glucose for a long time and so on[19–21]. In the collected
type 2 diabetes mellitus patients of above research, the age of
patients with ketosis is signiﬁcant lower than patients without
ketosis and glycosylated hemoglobin contents are signiﬁcant
higher than patients without ketosis, while the BMI index and
blood fat content had no signiﬁcant difference with patients
without ketosis. Glycosylated hemoglobin content is the index
to reﬂect blood glucose control situation of diabetes mellitus
patients in previous 2–3 months. The higher content explainedybutyric acid contents.
= 0.490, P < 0.01; Right: The correlation of serum CRP contents and
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months. Combining with the analysis result showed that the
occurrence of type 2 diabetic ketosis is mainly associated with
poor long-term blood sugar control and the occurrence of risk
of ketosis in young patients is relatively high. However, the
association has not yet been found in obesity, blood lipid
metabolism condition, and type 2 diabetes mellitus patients with
ketosis, which is not consistent with the existing research results
and may be due to smaller sample size in this study.
Diabetic ketosis is a kind of acute complication and its body
is in a state of inﬂammation. A variety of proinﬂammatory
factors generate a mass of synthesis and secretion in the process
of quickly raising blood sugar and mass-produced blood ketone.
Some studies have conﬁrmed that in the process of the pro-
gression of diabetic ketosis, all the generation of proin-
ﬂammatory cytokine (IL-6) and suppression of inﬂammatory
cytokines (IL-10) are signiﬁcantly increased[7,22]. IL-6 can pro-
mote inﬂammatory response and participate in the occurrence of
concurrent change of ketosis such as pulmonary edema and
hydrocephalus, while IL-10 is the expression of its compensa-
tion in body and can exert protective effect by reducing endo-
thelial permeability[23,24]. In a state of inﬂammation, IL-6 will
induce hepatic cell to compound a mass of CRP. In recent years,
foreign study has reported that there is a correlation between the
change of serum CRP content and type 1 diabetes mellitus pa-
tients ketosis and ketoacidosis, which showed that there is a
correlation between the generation of ketone body and CRP[8–10].
Nevertheless, the change condition of serum CRP content of
type 2 diabetes mellitus ketosis patients has not yet been
reported clearly by far. The research of Namavar Jahromi B
analyzed 68 cases in gestational diabetes mellitus (GDM) and
found that GDM combined with ketosis will not increase CRP
content[25]. Whereas, in view of the endocrine environment
existing signiﬁcant change in body in the process of
pregnancy and the placenta tissue itself can synthesize and
secrete a large number of CRP, the change of CRP synthesis
of hepatic cell is hardly expressed in serum when diabetes
mellitus combined with ketosis. We analyzed serum CRP
content in type 2 diabetes mellitus patients and found that
serum CRP content of patients in DK group is signiﬁcant
higher than that in NC group. This preliminary illustrated that
type 2 diabetes mellitus patients combined with ketosis are
similar with type 1 diabetes mellitus patients combined with
ketosis, where body is in a state of inﬂammation and serum
CRP content is signiﬁcantly elevated.
b-Hydroxybutyric acid is the main component of ketone
body and also is the main substance which causes diabetic
ketosis accounting for about 78%, while acetoacetic acid and
acetone account for 20% and 2% respectively[26,27]. In clinic,
diabetic ketosis is diagnosed commonly by detecting urine
acetone body; the method is sodium nitroprusside and can
only semi-quantitative detect the acetyl acetate and acetone,
while it almost didn't react with b-hydroxybutyric acid. How-
ever, in the process of the occurrence of diabetic ketosis, the
production of b-hydroxybutyric acid is increased signiﬁcantly,
while the production of acetone and acetoacetic acid are reduced
relatively. At this moment, through the test of acetone and
acetoacetic acid in urine to evaluate the production situation of
ketone body in vivo can cause false negative[28,29]. From the
generation process and discharge process of ketone body
in vivo, the change of blood ketone body is ahead of urine
ketone body, while b-hydroxybutyric acid is also the maincomponent of blood ketone body. Therefore, the generation
condition of ketone body of diabetes mellitus patients with
ketosis can be evaluated more accurately through detecting the
blood ketone body and b-hydroxybutyric acid content[30]. In
the above research, we analyzed and found that all the blood
ketone body content and b-hydroxybutyric acid are elevated
signiﬁcantly and have a positive correlation with serum CRP
content. This means that the change of CRP content in type 2
diabetes mellitus patients is closely related to the generation of
ketone body. The generation condition of ketone body and the
severity of patients' condition of ketosis can be evaluated
through detecting serum CRP content.
In conclusion, poor control of blood glucose for a long time
and strengthened inﬂammatory response are related to the state
of acute ketosis of type 2 diabetes mellitus patients. Serum CRP
content of patients with ketosis is increased signiﬁcantly and can
be used to evaluate the degree of ketosis.
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